BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26069183)

  • 1. CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease.
    Anderson AM; Fennema-Notestine C; Umlauf A; Taylor MJ; Clifford DB; Marra CM; Collier AC; Gelman BB; McArthur JC; McCutchan JA; Simpson DM; Morgello S; Grant I; Letendre SL;
    J Neurovirol; 2015 Oct; 21(5):559-67. PubMed ID: 26069183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy.
    Anderson AM; Harezlak J; Bharti A; Mi D; Taylor MJ; Daar ES; Schifitto G; Zhong J; Alger JR; Brown MS; Singer EJ; Campbell TB; McMahon DD; Buchthal S; Cohen R; Yiannoutsos C; Letendre SL; Navia BA;
    J Acquir Immune Defic Syndr; 2015 May; 69(1):29-35. PubMed ID: 25622053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.
    Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls RL; Taylor-Robinson SD; Emery S; Cooper DA;
    Neuroradiology; 2012 Dec; 54(12):1331-9. PubMed ID: 22772471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.
    Cohen RA; Harezlak J; Gongvatana A; Buchthal S; Schifitto G; Clark U; Paul R; Taylor M; Thompson P; Tate D; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B;
    J Neurovirol; 2010 Nov; 16(6):435-44. PubMed ID: 20961212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals.
    Letendre SL; Zheng JC; Kaul M; Yiannoutsos CT; Ellis RJ; Taylor MJ; Marquie-Beck J; Navia B;
    J Neurovirol; 2011 Feb; 17(1):63-9. PubMed ID: 21246320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
    Bladowska J; Zimny A; Kołtowska A; Szewczyk P; Knysz B; Gąsiorowski J; Furdal M; Sąsiadek MJ
    Eur J Radiol; 2013 Apr; 82(4):686-92. PubMed ID: 23246331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy.
    Sailasuta N; Ananworanich J; Lerdlum S; Sithinamsuwan P; Fletcher JL; Tipsuk S; Pothisri M; Jadwattanakul T; Jirajariyavej S; Chalermchai T; Catella S; Busovaca E; Desai A; Paul R; Valcour V;
    J Acquir Immune Defic Syndr; 2016 Jan; 71(1):24-30. PubMed ID: 26258565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.
    Gongvatana A; Harezlak J; Buchthal S; Daar E; Schifitto G; Campbell T; Taylor M; Singer E; Algers J; Zhong J; Brown M; McMahon D; So YT; Mi D; Heaton R; Robertson K; Yiannoutsos C; Cohen RA; Navia B;
    J Neurovirol; 2013 Jun; 19(3):209-18. PubMed ID: 23613008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peripheral monocyte interferon phenotype in HIV infection correlates with a decrease in magnetic resonance spectroscopy metabolite concentrations.
    Pulliam L; Rempel H; Sun B; Abadjian L; Calosing C; Meyerhoff DJ
    AIDS; 2011 Sep; 25(14):1721-6. PubMed ID: 21750421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study.
    Mohamed MA; Barker PB; Skolasky RL; Selnes OA; Moxley RT; Pomper MG; Sacktor NC
    Magn Reson Imaging; 2010 Nov; 28(9):1251-7. PubMed ID: 20688449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
    Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
    Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter damage, neuroinflammation, and neuronal integrity in HAND.
    Alakkas A; Ellis RJ; Watson CW; Umlauf A; Heaton RK; Letendre S; Collier A; Marra C; Clifford DB; Gelman B; Sacktor N; Morgello S; Simpson D; McCutchan JA; Kallianpur A; Gianella S; Marcotte T; Grant I; Fennema-Notestine C;
    J Neurovirol; 2019 Feb; 25(1):32-41. PubMed ID: 30291567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of Brain Metabolites in Adults With HIV: A Systematic Meta-analysis of Magnetic Resonance Spectroscopy Studies.
    Dahmani S; Kaliss N; VanMeter JW; Moore DJ; Ellis RJ; Jiang X
    Neurology; 2021 Sep; 97(11):e1085-e1096. PubMed ID: 34253633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children.
    Van Dalen YW; Blokhuis C; Cohen S; Ter Stege JA; Teunissen CE; Kuhle J; Kootstra NA; Scherpbier HJ; Kuijpers TW; Reiss P; Majoie CBLM; Caan MWA; Pajkrt D
    Medicine (Baltimore); 2016 Mar; 95(12):e3093. PubMed ID: 27015179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV brain latency as measured by CSF BcL11b relates to disrupted brain cellular energy in virally suppressed HIV infection.
    Cysique LA; Jugé L; Lennon MJ; Gates TM; Jones SP; Lovelace MD; Rae CD; Johnson TP; Nath A; Brew BJ
    AIDS; 2019 Mar; 33(3):433-441. PubMed ID: 30475266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementia.
    Mohamed MA; Lentz MR; Lee V; Halpern EF; Sacktor N; Selnes O; Barker PB; Pomper MG
    Radiology; 2010 Feb; 254(2):577-86. PubMed ID: 20093528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients.
    Chang L; Ernst T; St Hillaire C; Conant K
    Antivir Ther; 2004 Jun; 9(3):431-40. PubMed ID: 15259906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART.
    Harezlak J; Cohen R; Gongvatana A; Taylor M; Buchthal S; Schifitto G; Zhong J; Daar ES; Alger JR; Brown M; Singer EJ; Campbell TB; McMahon D; So YT; Yiannoutsos CT; Navia BA;
    J Neurovirol; 2014 Jun; 20(3):294-303. PubMed ID: 24696364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study.
    Cysique LA; Moffat K; Moore DM; Lane TA; Davies NW; Carr A; Brew BJ; Rae C
    PLoS One; 2013; 8(4):e61738. PubMed ID: 23620788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.